163 related articles for article (PubMed ID: 38282535)
1. The discovery of subunit-selective GluN1/GluN2B NMDAR antagonist via pharmacophere-based virtual screening.
Tang J; Jin J; Huang Z; An F; Huang C; Jiang W
Exp Biol Med (Maywood); 2023 Dec; 248(24):2560-2577. PubMed ID: 38282535
[TBL] [Abstract][Full Text] [Related]
2. Identifying potential GluN2B subunit containing N-Methyl-D-aspartate receptor inhibitors: an integrative
Singh R; Ganeshpurkar A; Kumar D; Kumar D; Kumar A; Singh SK
J Biomol Struct Dyn; 2020 Jun; 38(9):2533-2545. PubMed ID: 31232189
[TBL] [Abstract][Full Text] [Related]
3. Deconstruction - Reconstruction: Analysis of the Crucial Structural Elements of GluN2B-Selective, Negative Allosteric NMDA Receptor Modulators with 3-Benzazepine Scaffold.
Ritter N; Korff M; Markus A; Schepmann D; Seebohm G; Schreiber JA; Wünsch B
Cell Physiol Biochem; 2021 Mar; 55(S3):1-13. PubMed ID: 33656308
[TBL] [Abstract][Full Text] [Related]
4. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists.
Stroebel D; Buhl DL; Knafels JD; Chanda PK; Green M; Sciabola S; Mony L; Paoletti P; Pandit J
Mol Pharmacol; 2016 May; 89(5):541-51. PubMed ID: 26912815
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel brain-penetrant GluN2B NMDAR antagonists via pharmacophore-merging strategy as anti-stroke therapeutic agents.
Xu Q; Hu M; Li J; Ma X; Chu Z; Zhu Q; Zhang Y; Zhu P; Huang Y; He G
Eur J Med Chem; 2022 Jan; 227():113876. PubMed ID: 34710748
[TBL] [Abstract][Full Text] [Related]
6. Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease.
Shukla R; Singh TR
J Biomol Struct Dyn; 2020 Jan; 38(1):248-262. PubMed ID: 30688165
[TBL] [Abstract][Full Text] [Related]
7. Exploring the overlapping binding sites of ifenprodil and EVT-101 in GluN2B-containing NMDA receptors using novel chicken embryo forebrain cultures and molecular modeling.
Fjelldal MF; Freyd T; Evenseth LM; Sylte I; Ring A; Paulsen RE
Pharmacol Res Perspect; 2019 Jun; 7(3):e00480. PubMed ID: 31164987
[TBL] [Abstract][Full Text] [Related]
8. Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors.
Karakas E; Simorowski N; Furukawa H
Nature; 2011 Jun; 475(7355):249-53. PubMed ID: 21677647
[TBL] [Abstract][Full Text] [Related]
9. Repurposing of phyto-ligand molecules from the honey bee products for Alzheimer's disease as novel inhibitors of BACE-1: small molecule bioinformatics strategies as amyloid-based therapy.
Nisa N; Rasmita B; Arati C; Uditraj C; Siddhartha R; Dinata R; Bhanushree B; Bidanchi RM; Manikandan B; Laskar SA; Abinash G; Pori B; Roy VK; Gurusubramanian G
Environ Sci Pollut Res Int; 2023 Apr; 30(17):51143-51169. PubMed ID: 36808033
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of synaptic GluN2B subunit-containing N-methyl-D-aspartate receptors: a physiological brake on CA1 neuron α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid hyperexcitability during benzodiazepine withdrawal.
Shen G; Tietz EI
J Pharmacol Exp Ther; 2011 Jan; 336(1):265-73. PubMed ID: 20935233
[TBL] [Abstract][Full Text] [Related]
11. An in-silico investigation based on molecular simulations of novel and potential brain-penetrant GluN2B NMDA receptor antagonists as anti-stroke therapeutic agents.
El Fadili M; Er-Rajy M; Ali Eltayb W; Kara M; Imtara H; Zarougui S; Al-Hoshani N; Hamadi A; Elhallaoui M
J Biomol Struct Dyn; 2024 Aug; 42(12):6174-6188. PubMed ID: 37428078
[TBL] [Abstract][Full Text] [Related]
12. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of N-methyl-D-aspartate receptor-mediated excitatory postsynaptic potentials and synaptic plasticity to TCN 201 and TCN 213 in rat hippocampal slices.
Izumi Y; Zorumski CF
J Pharmacol Exp Ther; 2015 Feb; 352(2):267-73. PubMed ID: 25413830
[TBL] [Abstract][Full Text] [Related]
14. GluN2B/N-methyl-D-aspartate Receptor Antagonists: Advances in Design, Synthesis, and Pharmacological Evaluation Studies.
Ugale V; Dhote A; Narwade R; Khadse S; Reddy PN; Shirkhedkar A
CNS Neurol Disord Drug Targets; 2021; 20(9):822-862. PubMed ID: 33687902
[TBL] [Abstract][Full Text] [Related]
15. Repurposing of cefpodoxime proxetil as potent neuroprotective agent through computational prediction and in vitro validation.
Quan J; Ma C; Wang Y; Hu B; Zhang D; Zhang Z; Wang J; Cheng M
J Biomol Struct Dyn; 2021 Jul; 39(11):3975-3985. PubMed ID: 32448083
[TBL] [Abstract][Full Text] [Related]
16. GluN2B-containing NMDA receptors as possible targets for the neuroprotective and antidepressant effects of fluoxetine.
Kiss JP; Szasz BK; Fodor L; Mike A; Lenkey N; Kurkó D; Nagy J; Vizi ES
Neurochem Int; 2012 Jan; 60(2):170-6. PubMed ID: 22197911
[TBL] [Abstract][Full Text] [Related]
17. Unveiling the molecular basis of lobeline's allosteric regulation of NMDAR: insights from molecular modeling.
Remya C; Variyar EJ; Omkumar RV; Sadasivan C; Dileep KV
Sci Rep; 2023 Dec; 13(1):22418. PubMed ID: 38104236
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and Biological Evaluation of
Lin G; Xu Q; Li J; Chu Z; Ma X; Zhu Q; Zhao Y; Mo J; Ye W; Shao L; Fang T; He M; Yue S; Dai M
J Med Chem; 2024 Mar; 67(5):3358-3384. PubMed ID: 38413367
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro characterisation of ifenprodil-based fluorescein conjugates as GluN1/GluN2B N-Methyl-D-aspartate receptor antagonists.
Dhilly M; Becerril-Ortega J; Colloc'h N; MacKenzie ET; Barré L; Buisson A; Nicole O; Perrio C
Chembiochem; 2013 Apr; 14(6):759-69. PubMed ID: 23532918
[TBL] [Abstract][Full Text] [Related]
20. Identification of Leading Compounds from
Islam MN; Pramanik MEA; Hossain MA; Rahman MH; Hossen MS; Islam MA; Miah MMZ; Ahmed I; Hossain AM; Haque MJ; Islam AM; Ali MN; Jahan RA; Haque ME; Rahman MM; Hasan MS; Rahman MM; Kabir MM; Basak PM; Sarkar MAM; Islam MS; Rahman MR; Prodhan AA; Mosaddik A; Haque H; Fahmin F; Das HS; Islam MM; Emtia C; Gofur MR; Liang A; Akbar SMF
Euroasian J Hepatogastroenterol; 2023; 13(2):89-107. PubMed ID: 38222948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
